CRIS Current Research Information System

RAVAIOLI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.030
NA - Nord America 9.014
EU - Europa 4.681
AF - Africa 550
Continente sconosciuto - Info sul continente non disponibili 469
SA - Sud America 463
OC - Oceania 12
Totale 24.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.794
SG - Singapore 2.340
VN - Vietnam 2.338
CN - Cina 2.182
IT - Italia 1.522
GB - Regno Unito 625
HK - Hong Kong 564
DE - Germania 554
SE - Svezia 482
IN - India 347
BR - Brasile 324
KR - Corea 318
BD - Bangladesh 298
NL - Olanda 265
FR - Francia 245
IE - Irlanda 186
JP - Giappone 181
RU - Federazione Russa 159
CI - Costa d'Avorio 152
ZA - Sudafrica 136
FI - Finlandia 118
CA - Canada 109
SC - Seychelles 105
AT - Austria 75
BG - Bulgaria 71
CH - Svizzera 66
ID - Indonesia 65
PH - Filippine 61
UA - Ucraina 58
TG - Togo 56
TH - Thailandia 56
ES - Italia 50
AR - Argentina 48
PK - Pakistan 48
NG - Nigeria 42
MX - Messico 41
IQ - Iraq 39
TR - Turchia 37
PL - Polonia 36
EC - Ecuador 34
EE - Estonia 34
JO - Giordania 31
TW - Taiwan 31
BE - Belgio 26
EG - Egitto 18
CR - Costa Rica 16
JM - Giamaica 15
CL - Cile 14
HR - Croazia 13
SA - Arabia Saudita 13
GR - Grecia 12
LT - Lituania 12
PT - Portogallo 12
VE - Venezuela 12
AU - Australia 11
IR - Iran 11
RO - Romania 11
CO - Colombia 10
MY - Malesia 10
TT - Trinidad e Tobago 10
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
HN - Honduras 7
LB - Libano 7
PE - Perù 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
KE - Kenya 6
KZ - Kazakistan 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
DZ - Algeria 5
IL - Israele 5
MA - Marocco 5
NP - Nepal 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
KG - Kirghizistan 4
MK - Macedonia 4
NI - Nicaragua 4
PR - Porto Rico 4
AZ - Azerbaigian 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MD - Moldavia 3
MT - Malta 3
OM - Oman 3
PA - Panama 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
Totale 23.723
Salva come PNG Salva come JPEG
Città #
Singapore 1.680
Ashburn 1.011
Fairfield 781
Hefei 622
Ho Chi Minh City 589
San Jose 564
Hanoi 558
Hong Kong 509
Southend 503
Chandler 415
Bologna 323
New York 284
Santa Clara 280
Seoul 280
Boardman 265
Beijing 246
Council Bluffs 242
Seattle 226
Woodbridge 217
Los Angeles 204
Houston 198
Dublin 183
Wilmington 183
Cambridge 174
Dallas 161
Princeton 157
Abidjan 152
Tokyo 144
Milan 130
Ann Arbor 125
Lauterbourg 109
Da Nang 104
Buffalo 89
Haiphong 88
Rome 83
Johannesburg 81
São Paulo 79
Frankfurt am Main 78
Munich 69
Sofia 69
Helsinki 66
Dong Ket 62
Las Vegas 61
Bengaluru 59
Turin 57
Lomé 56
Phoenix 56
Redondo Beach 55
Nanjing 49
Vienna 48
Florence 47
Redmond 46
Atlanta 43
Westminster 43
Berlin 41
Guangzhou 41
North Charleston 41
Bremen 39
Abeokuta 38
Shanghai 38
Bern 37
Brooklyn 37
Chicago 37
San Diego 37
Amsterdam 35
San Francisco 35
Orem 33
Des Moines 31
Jakarta 31
Medford 31
Amman 30
Redwood City 29
Turku 29
Denver 28
Boydton 27
Hải Dương 27
Biên Hòa 26
Dearborn 26
Hyderabad 26
Palermo 26
Warsaw 26
Brussels 25
Falkenstein 25
Jinan 25
London 25
The Dalles 25
Can Tho 24
Nuremberg 24
Bangkok 23
Bến Tre 23
Montreal 23
Stockholm 23
Naples 22
Tongling 22
Washington 22
Changsha 21
Lahore 21
Lappeenranta 21
Rimini 21
Wuhan 21
Totale 14.321
Salva come PNG Salva come JPEG
Nome #
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 434
Monofocal hepatocellular carcinoma: How much does size matter? 302
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 294
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 293
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 281
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 279
An all-natural, very low-calorie ketogenic diet (VLCKD) protocol has similar efficacy and safety to commercial meal replacements (whole or partial) in inducing weight loss: results from a prospective, controlled, 4-arm pragmatic trial (KOBE trial) 276
Diagnostic accuracy of 2D-SWE ultrasound for liver fibrosis assessment in MASLD: A multilevel random effects model meta-analysis 265
How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests 262
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 249
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 246
Pattern of macrovascular invasion in hepatocellular carcinoma 246
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 243
Small bites, big impact: The importance of evening snacks in patients with advanced chronic liver disease 243
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 243
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 242
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 241
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 236
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 234
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 228
The changing scenario of hepatocellular carcinoma in Italy: an update 227
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 225
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 223
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 222
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 219
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 218
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 214
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 210
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 209
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 207
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 203
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 199
Impact of first and further decompensation in patients with compensated ACLD due to MASLD 198
Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. 196
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 196
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 195
Gut Microbiota and Celiac Disease 194
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 193
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 192
Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness 191
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 189
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 187
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 185
IL28 polymorphism and HCC after DAAs for chronic hepatitis C 185
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 184
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 182
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 180
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 178
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 178
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 176
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 176
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 175
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 174
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 173
Metformin and the Liver: Unlocking the Full Therapeutic Potential 173
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 172
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 170
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 170
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study 168
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 168
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 167
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 166
Pancreatic ultrasound elastography is not useful to predict the risk of pancreatic fistulas after pancreatic resection 165
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 164
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 164
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 160
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 155
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 155
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C 154
Comparison of screening strategies with two new tests to score and diagnose varices needing treatment 152
Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease 152
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 150
Nutrition in patients with type 2 diabetes: Present knowledge and remaining challenges 150
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 149
Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility 148
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 148
Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?: A Systematic Review and Meta-analysis 147
Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases 146
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 146
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 146
A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma 146
Intestinal failure associated liver disease after weaning off home parenteral nutrition: a 12-month follow up 145
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 143
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 142
Transition of patients with chronic intestinal failure from paediatric to adult center 141
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 140
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 140
Malnutrition in hospitalized patients with SARS-CoV-2 infection 139
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 139
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 137
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 136
Non-invasive tests for the prediction of primary hepatocellular carcinoma 135
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis 131
New insights on portal hypertension's screening in people with cystic fibrosis 130
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 129
Spleen stiffness by ultrasound elastography 127
THU-086 - The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients 126
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 125
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 124
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 123
Totale 18.793
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.478
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.945 0 43 61 85 173 81 60 109 128 112 836 257
2022/20232.037 157 227 91 263 150 173 83 80 387 71 212 143
2023/2024958 61 134 72 75 92 241 33 65 53 66 36 30
2024/20253.616 134 421 363 243 411 166 284 150 70 352 287 735
2025/202611.414 963 1.223 955 846 784 486 1.413 460 2.191 832 664 597
2026/20271.408 879 529 0 0 0 0 0 0 0 0 0 0
Totale 24.219